Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
about
Amantadine for dyskinesia in Parkinson's diseaseThe monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosetsCellular replacement therapy for Parkinson's disease--where we are today?Worsening of levodopa-induced dyskinesias by motor and mental tasksThe alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's diseaseChronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease."Silly walks" in Parkinson's disease: unusual presentation of dopaminergic-induced dyskinesias.Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).Brittle Dyskinesia Following STN but not GPi Deep Brain Stimulation.A review of the assessment of dyskinesias.Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.Clinical spectrum of levodopa-induced complications.An ambulatory dyskinesia monitor.Polymorphism in candidate genes: implications for the risk and treatment of idiopathic Parkinson's disease.Levodopa, motor fluctuations and dyskinesia in Parkinson's disease.Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys.Managing the critical problems of advanced Parkinson's disease.Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessmentContinuous dopaminergic stimulation and novel formulations of dopamine agonists.Motor complications in Parkinson's disease.Subthalamic stimulation may inhibit the beneficial effects of levodopa on akinesia and gait.AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.Levodopa-induced Dyskinesia: Clinical Features, Pathophysiology, and Medical Management.Quantification of dyskinesia in Parkinson's disease: validation of a novel instrumental method.Which factors predict cognitive decline in Parkinson's disease?Dorsolateral prefrontal cortex: a possible target for modulating dyskinesias in Parkinson's disease by repetitive transcranial magnetic stimulation.Levodopa-induced ocular dyskinesias in Parkinson's disease.Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease.Mirror movements in Parkinson's disease: effect of dopaminergic drugs.Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease.Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex.Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's disease.Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan.Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.The hyperkinetic abnormal movements scale: a tool for measuring levodopa-induced abnormal movements in squirrel monkeys.Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation.Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia.
P2860
Q24248660-46E10B4A-2F40-48DE-A364-50BB3DE7CCB5Q28205148-3EAEC9DC-EF28-457E-8ADA-3B3B800DC6DBQ28206557-9A526450-3F09-4465-8519-0266F9550503Q28372142-9C498046-67DB-4E78-9A30-32919D25D865Q28373127-2F6E1245-9E53-4906-B4AD-ED7CFF4385FFQ30484170-37D4F98E-9421-4E00-B3E6-3E9AC4973662Q30502662-F67327D2-35E4-4BA3-BFA2-3DBFA0D968BCQ33704308-B4966185-4553-4D03-A88B-2E95F77A2BC7Q33728971-2C19F90C-BB66-4196-99AB-5006FE150386Q33737401-2C8A7481-EF5E-4BCE-BAD9-F5782C3D9CABQ34094008-89F5D443-DA79-4352-BEBA-FB97BE13B5EAQ34452721-29B1B63D-51B3-48EF-BEA4-AE21A4150DF1Q35454997-54D40A35-4444-48C0-AD8E-DB4001E65710Q35821201-FC80851F-0B89-4971-8CEC-3032D88FF481Q36573882-D6F805B7-7512-4D97-A71E-8AD795BEBEE7Q37398168-3E435F1D-7290-4746-BBB4-B84A6C9AAE2FQ37610215-0F64FCF0-12F4-4F0B-AC1A-FE5DF6E7C2CDQ37742224-EE88FFA4-C84A-465D-B372-C56ADEC38059Q37874192-260D21C9-9E28-490E-9F5F-FFE83FE98647Q37950426-43874D98-3BD9-43E1-8A4C-F3E238D9D70BQ38737626-5D8CB44F-89C3-446C-8C3D-6C99D567AF81Q39384819-E7A3EB45-7F7B-4ED1-8F74-A8B68444E334Q41626118-944238CB-0D32-4616-BA1C-5248DFE2A6A8Q41691617-A360FCCA-ABF8-4AA7-9C86-8A6BB311241EQ41876297-C5333F52-7039-40A1-AFD0-E1E6809B353BQ41935713-E7758F48-CE92-424A-9F0E-EBD3703BC6A4Q42164140-B688FF48-56B3-4D8D-ADE0-BDD96589633DQ42505427-03E1EAD6-7BE2-4261-962C-FC06F14AE9C0Q42718475-23F3FF9C-F94C-43EC-AB26-F6DB660652B4Q42859427-E2D520ED-75D3-487F-A16A-D368AB5AB504Q43072418-FCBB0A74-6BF8-4871-9CB3-DFB408A4BC77Q43507658-2AE7D1EA-FF9C-448C-A80C-B67E43EBF99FQ43570440-EEDA60A5-3DEF-4613-9FDA-0A635C458E59Q43693346-B657AB9F-AC6A-4ABB-9925-A64AE930D912Q43693354-0536918F-7F29-40B2-859C-8FB55AF01B49Q44165234-DC36663D-5A22-47A8-88DD-2044DD03C180Q44187507-63BBB94E-670F-48A5-8FBF-BB5D1AD47547Q44195730-DF4EB15D-37FF-4A8E-83C6-2111B0FE1D28Q44423669-22447D14-7A7B-4D77-9752-C9339D12E1FBQ45961748-AF9F7CD7-3BAC-4F96-9CFD-9256295CB39D
P2860
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
@en
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
@nl
type
label
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
@en
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
@nl
prefLabel
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
@en
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
@nl
P2093
P921
P356
P1433
P1476
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
@en
P2093
Lefebvre-Caparros D
Vidailhet M
P356
10.1002/MDS.870090103
P407
P50
P577
1994-01-01T00:00:00Z